Background: There is a growing scientific interest in the phenomenon of earworms, which are melodies that are heard and re-heard despite the absence of an external stimulus. Aim: The aim of this paper is to determine whether understanding earworms can shed light on mechanisms underlying auditory hallucinations in psychosis. Method: Using recent data sources, this report briefly reviews what is most relevant about musical hallucinations and earworms. Results: Musical hallucinations, like hallucinated voices, are more prevalent in women. In the elderly, they are often associated with hearing impairment. They are most distressing when they first begin, with the degree of distress inversely proportional to the extent to which they can be controlled. Earworms can be provoked both by the memory of past events and by the anticipation of future events. Strong emotion can trigger earworms, but so can boredom. Limitations: The neurobiology potentially involved in the phenomenon of earworms is not explored in this paper. The pertinence of the literature about earworms and musical hallucinations, while interesting, is of unproven relevance to pathological voices in psychotic illness. Conclusions: The clinical relevance, while unproven, is that addressing recurring memories, as well as managing strong emotions and avoiding occupations that lead to boredom are all strategies worth trying when treating pathologicalauditory hallucinations Show less

The purpose of this paper is to review the literature linking schizophrenia with chronic inflammation and gluten sensitivity. In addition, the paper discusses the need for dietary interventions that may improve multiple health outcomes for patients. Individuals with schizophrenia are at much greater risk for the development of additional autoimmune disorders. Second generation anti-psychotic medications are the most effective treatment for schizophrenia, but there are numerous potential side effects to the medications. More specifically, individuals with schizophrenia who are treated with SGAs are at increased risk for obesity, diabetes, as well as elevated lipids and blood pressure. An effective evidence-based dietary intervention has the potential to improve numerous outcomes for individuals with schizophrenia. Show less

Objectives This study was designed to assess the demographic characteristics, prevalence of metabolic syndrome (MetSy) among patients with schizophrenia in Saudi Arabia. Methods This is a disease-oriented and observational study. Schizophrenia was defined by DSM-IV criteria. MetSy were assessed based on the international criteria (NCEP-ATP III and AHA/NHLB). Results 90% of the participants are without a university degree and 56.4% are single. Chronic and acute cases of schizophrenia were 95% and 5%, respectively. The treatment of schizophrenia was combination therapy and monotherapy with percentages of 56% and 44%, respectively. Systolic and diastolic blood pressures were 121.92±11.07 mmHg and 77.29±0.45 mmHg, respectively. Surprisingly, all patients have abnormal HDL. A mean waist circumference of 90.23±14.88 cm for men, and 93.38±15.28 cm for women. The analysis of 101 patients showed a prevalence of the MetSy is 15.8%. Chi-square test of independence showed lack of independency of MetSy on type of therapy. Modeling of MetSy and risk factors was also conducted. Conclusion The metabolic syndrome is greatly established among schizophrenic patients. It signifies a vital hazard for metabolic and cardiovascular ailments. Evaluation of the incidence and examining of the related threats of the metabolic syndrome should be an element of the clinical managing of patients cured with antipsychotics. Show less